157 related articles for article (PubMed ID: 27480280)
1. Bardoxolone methyl modulates efflux transporter and detoxifying enzyme expression in cisplatin-induced kidney cell injury.
Atilano-Roque A; Aleksunes LM; Joy MS
Toxicol Lett; 2016 Sep; 259():52-59. PubMed ID: 27480280
[TBL] [Abstract][Full Text] [Related]
2. In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
Kurosaki Y; Imoto A; Kawakami F; Ouchi M; Morita A; Yokoba M; Takenaka T; Ichikawa T; Katagiri M; Nielsen R; Ishii N
Mol Cell Biochem; 2022 Mar; 477(3):689-699. PubMed ID: 34973124
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.
Aleksunes LM; Goedken MJ; Rockwell CE; Thomale J; Manautou JE; Klaassen CD
J Pharmacol Exp Ther; 2010 Oct; 335(1):2-12. PubMed ID: 20605904
[TBL] [Abstract][Full Text] [Related]
4. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
Noel S; Zheng L; Navas-Acien A; Fuchs RJ
Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
[TBL] [Abstract][Full Text] [Related]
6. A Point Mutation at C151 of
Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
[TBL] [Abstract][Full Text] [Related]
7. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
[TBL] [Abstract][Full Text] [Related]
8. [Schisandrin B protects against nephrotoxicity induced by cisplatin in HK-2 cells via Nrf2-ARE activation].
Li M; Jin J; Li J; Guan CW; Wang WW; Qiu YW; Huang ZY
Yao Xue Xue Bao; 2012 Nov; 47(11):1434-9. PubMed ID: 23387073
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.
Tian C; Gao L; Zhang A; Hackfort BT; Zucker IH
J Pharmacol Exp Ther; 2019 Dec; 371(3):642-651. PubMed ID: 31601682
[TBL] [Abstract][Full Text] [Related]
10. CDDO-Me protects normal lung and breast epithelial cells but not cancer cells from radiation.
El-Ashmawy M; Delgado O; Cardentey A; Wright WE; Shay JW
PLoS One; 2014; 9(12):e115600. PubMed ID: 25536195
[TBL] [Abstract][Full Text] [Related]
11. CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
Xue P; Hu X; Powers J; Nay N; Chang E; Kwon J; Wong SW; Han L; Wu TH; Lee DJ; Tseng H; Ko CC
Biochem Biophys Res Commun; 2019 Apr; 511(3):637-643. PubMed ID: 30826055
[TBL] [Abstract][Full Text] [Related]
12. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.
Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817
[TBL] [Abstract][Full Text] [Related]
13. CDDO-Me Attenuates Vasogenic Edema and Astroglial Death by Regulating NF-κB p65 Phosphorylations and Nrf2 Expression Following Status Epilepticus.
Kim MJ; Park H; Choi SH; Kong MJ; Kim JE; Kang TC
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31574956
[TBL] [Abstract][Full Text] [Related]
14. Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.
Wu QQ; Wang Y; Senitko M; Meyer C; Wigley WC; Ferguson DA; Grossman E; Chen J; Zhou XJ; Hartono J; Winterberg P; Chen B; Agarwal A; Lu CY
Am J Physiol Renal Physiol; 2011 May; 300(5):F1180-92. PubMed ID: 21289052
[TBL] [Abstract][Full Text] [Related]
15. Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling.
Gee MS; Kang SB; Kim N; Choi J; Kim NJ; Kim BJ; Inn KS; Lee JK
Pharmacology; 2018; 102(1-2):105-113. PubMed ID: 29953997
[TBL] [Abstract][Full Text] [Related]
16. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
17. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
Wang YY; Yang YX; Zhe H; He ZX; Zhou SF
Drug Des Devel Ther; 2014; 8():2075-88. PubMed ID: 25364233
[TBL] [Abstract][Full Text] [Related]
18. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
[TBL] [Abstract][Full Text] [Related]
19. Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway.
Wu J; Liu X; Fan J; Chen W; Wang J; Zeng Y; Feng X; Yu X; Yang X
Toxicology; 2014 Apr; 318():22-31. PubMed ID: 24530882
[TBL] [Abstract][Full Text] [Related]
20. Cadmium exposure induces rat proximal tubular cells injury via p62-dependent Nrf2 nucleus translocation mediated activation of AMPK/AKT/mTOR pathway.
Dong W; Liu G; Zhang K; Tan Y; Zou H; Yuan Y; Gu J; Song R; Zhu J; Liu Z
Ecotoxicol Environ Saf; 2021 May; 214():112058. PubMed ID: 33714136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
